BABATUNDE SAMUEL OBADAWO

Mr. BABATUNDE SAMUEL OBADAWO

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2020 in Journal of Genetic Engineering and Biotechnology
Verified
Journal Article
Open access
PDF file
FIFabian Ikwu
Fabian Ikwu
YIYusuf Isyaku
Yusuf Isyaku
BOBABATUNDE SAMUEL OBADAWO
BABATUNDE SAMUEL OBADAWO
HLHadiza Abdulrahman Lawal
Hadiza Abdulrahman Lawal
SASamuel Akolade Ajibowu
Samuel Akolade Ajibowu
Colorectal cancer is common to both sexes; third in terms of morbidity and second in terms of mortality, accounting for 10% and 9.2% of cancer cases in men and women globally. Although drugs such as bevacizumab, Camptosar, and cetuximab are being used to manage colorectal cancer, the efficacy of the drugs has been reported to vary from patient to patient. These drugs have also been reported to have varying degrees of side effects; thus, the need for novel drug therapies with better efficacy and lesser side effects. In silico drugs design methods provide a faster and cost-effect method for lead identification and optimization. The aim of this study, therefore, was to design novel imidazol-5-ones via in silico design methods. A QSAR model was built using the genetic function algorithm method to model the cytotoxicity of the compounds against the HCT116 colorectal cancer cell line. The built model had statistical parameters; R2 = 0.7397, R2adj = 0.6712, Q2cv = 0.5547, and R2ext. = 0.7202 and revealed the cytotoxic activity of the compounds to be dependent on the molecular descriptors nS, GATS5s, VR1_Dze, ETA_dBetaP, and L3i. These molecular descriptors were poorly correlated (VIF < 4.0) and made unique contributions to the built model. The model was used to design a novel set of derivatives via the ligand-based drug design approach. Compounds e, h, j, and l showed significantly better cytotoxicity (IC50 < 5.0 μM) compared to the template. The interaction of the compounds with the CDK2 enzyme (PDB ID: 6GUE) was investigated via molecular docking study. The compounds were potent inhibitors of the enzyme having binding affinity of range −10.8 to −11.0 kcal/mol and primarily formed hydrogen bond interaction with lysine, aspartic acid, leucine, and histidine amino acid residues of the enzyme. The QSAR model built was stable, robust, and had a good predicting ability. Thus, predictions made by the model were reliably employed in further in silico studies. The compounds designed were more active than the template and showed better inhibition of the CDK2 enzyme compared to the standard drugs sorafenib and kenpaullone.

1 December 2021 in Journal of Genetic Engineering and Biotechnology
Verified
Journal Article
Open access
PDF file
OOOluwatoba Emmanuel Oyeneyin
Oluwatoba Emmanuel Oyeneyin
BOBABATUNDE SAMUEL OBADAWO
BABATUNDE SAMUEL OBADAWO
AOAdesoji Alani Olanrewaju
Adesoji Alani Olanrewaju
TOTaoreed Olakunle Owolabi
Taoreed Olakunle Owolabi
FGFahidat Adedamola Gbadamosi
Fahidat Adedamola Gbadamosi
HMHelen Omonipo Modamori
Helen Omonipo Modamori
The number of cancer-related deaths is on the increase, combating this deadly disease has proved difficult owing to resistance and some serious side effects associated with drugs used to combat it. Therefore, scientists continue to probe into the mechanism of action of cancer cells and designing novel drugs that could combat this disease more safely and effectively. Here, we developed a genetic function approximation model to predict the bioactivity of some 2-alkoxyecarbonyl esters and probed into the mode of interaction of these molecules with an epidermal growth factor receptor (3POZ) using the three-dimensional quantitative structure activity relationship (QSAR), extreme learning machine (ELM), and molecular docking techniques. The developed QSAR model with predicted (R2pred) of 0.756 showed that the model was fit to be validated parameter for a built model and also proved that the developed model could be used in practical situation, R2 for training set (0.9929) and test set (0.8397) confirmed that the model could successfully predict the activity of new compounds due to its correlation with the experimental activity, the models generated with ELM models showed improved prediction of the activity of the molecules. The lead compounds (22 and 23) had binding energies of −6.327 and −7.232 kcalmol−1 for 22 and 23 respectively and displayed better inhibition at the binding sites of 3POZ when compared with that of the standard drug, chlorambucil (−6.0 kcalmol−1). This could be attributed to the presence of double bonds and the α-ester groups. The QSAR and ELM models had good prognostic ability and could be used to predict the bioactivity of novel anti-proliferative drugs.

19 May 2021 in Journal of Medical Virology
Verified
Journal Article
Open access
PDF file
AAAbdullahi Aborode
Abdullahi Aborode
OOOluwatosin A. Olofinsao
Oluwatosin A. Olofinsao
EOEkwebelem Osmond
Ekwebelem Osmond
ABAbiokpoyanam P. Batubo
Abiokpoyanam P. Batubo
OFOmowonuola Fayemiro
Omowonuola Fayemiro
EFEmmanuel A. Fajemisin
Emmanuel A. Fajemisin
The World Health Organization (WHO) in Africa and Africa Center Disease Control (Africa CDC) urge the international community and different countries in Africa to ensure sustainable and concrete action to ensure equal and easy access to the COVID‐19 vaccines, as different countries in Africa are still struggling to develop a safe and effective strategy to ensure equal vaccine distribution, if available. Africa CDC has called on the international community to come together to help Africa with COVID‐19 vaccines to make equal the vaccine distribution among African countries as many cannot afford the vaccine costs due to the level of poverty and other negative factors. The African Union has endorsed the need for Africa to develop a framework to actively engage in easy accessibility to COVID‐19 vaccines, which will allow different countries in Africa to take easy steps that will strengthen the local vaccine distribution system, building workforce skills and knowledge, and enrich outreach services in Africa. The article discusses the need for equal access in the distribution of COVID‐19 vaccines in Africa, the challenges, and the necessary recommendations that can help to mitigate these challenges.


11 April 2025 in Molecules
Verified
Journal Article
Open access
PDF file
UBUzoamaka Clara Bokolo
Uzoamaka Clara Bokolo
RDRavindika Dissanayake
Ravindika Dissanayake
SGSamir Ghosh
Samir Ghosh
SNShadia Nada
Shadia Nada
BOBABATUNDE SAMUEL OBADAWO
BABATUNDE SAMUEL OBADAWO
Steven J. SucheckSteven J. Sucheck
Steven J. Sucheck
Oligosaccharides and glycoconjugates play essential roles in various biological processes such as cellular recognition and signaling, and thus have attracted tremendous attention in the synthetic and biological communities over the past few decades. Contributing to this field, we have achieved the synthesis of the aminoxyglycoside pentasaccharide subunit of Pseudomonas aeruginosa polysaccharide synthesis locus (Psl) exopolysaccharide through an efficient 23 step process. This pentasaccharide was designed with an aminooxy derivative at the reducing end, which was used in a 2-step oxime-based bioconjugation to the protein carrier CRM197, with an epitope ratio of 1:4. The conjugate vaccine could generate anti-Psl antibodies that could recognize P. aeruginosa PAO1 bacteria and initiate opsonophagocytic killing of the bacteria. In addition, the aminoxyglycoside could be conveniently conjugated to a bifunctional aldehyde-biotin reagent, which can be used for quantifying antibody titers in vaccination studies.

6 January 2022 in Egyptian Journal of Basic and Applied Sciences
Verified
Journal Article
Open access
AAAbdullahi Aborode
Abdullahi Aborode
SOSherifdeen Bamidele Onigbinde
Sherifdeen Bamidele Onigbinde
KSKhadijah Omoshalewa Sanusi
Khadijah Omoshalewa Sanusi
NANoah Alaba
Noah Alaba
ARAderinola H. Rasaq-Lawal
Aderinola H. Rasaq-Lawal
Gaber El-Saber BatihaGaber El-Saber Batiha
Gaber El-Saber Batiha
COVID-19-related morbidity and mortality are significantly increased with increasing age and the presence of co-existing health conditions, such as cancer and cardiovascular disease. While most infected people recover, even very young and otherwise healthy patients may unpredictably succumb to this disease. COVID-19 is highly susceptible to Angiotensin-converting enzyme 2 (ACE2) and Transmembrane protease-serine 2 (TMPRSS2) polymorphisms altering the angiotensinogen-ACE2 interactions, such as p. Arg514Gly and its prevalence. The article describes the role of understanding the genetic basis of COVID-19 and its susceptibility to human genes.